Pakistan’s pharma sector eyes US market expansion with new tariff advantage
New tariff policy provides Pakistan a competitive edge over India and China; regulatory approvals from US authorities will be crucial for unlocking this potentialÂ
Government approves exemption for import of unregistered lifesaving drugs for hospitals
Exemption covers anti-cancer, cardiac, and essential lifesaving drugs, allowing hospitals to access therapies not yet registered in Pakistan for another five yearsÂ
Transparency International says some branded medicines in Pakistan cost up to 4,000% more than generics
Transparency International Pakistan urges government to implement generic medicine policy to address significant price disparities between branded and non-branded drugs
Haleon Pakistan targets expansion to 19 countries, aims for 10% export sales share
Haleon plans to boost exports and local manufacturing, with focus on Vietnam, Philippines and local sourcing to reduce import reliance
Pakistan to import insulin from Russia through pharmaceutical joint ventures
Joint ventures to strengthen insulin supply, with focus on local manufacturing and price regulation
Highnoon Laboratories partners with Bangladesh-based Beximco Pharmaceuticals for strategic collaboration
Both firms sign MoU to distribute and market specialised pharmaceutical products in Pakistan, focusing on key therapeutic areas
Pakistan’s pharmaceutical exports hit 34% growth in FY25, marking a two-decade high
Exports of locally produced medicines reach $457 million, with deregulation policy boosting growth
Pakistan’s retail pharma sector surpasses Rs1.049 trillion in salesÂ
Data from IQVIA reveals steep price hikes drive growth as medicine consumption shows minimal increase, raising concerns over affordability
PSW, DRAP launch digital certificates to boost pharmaceutical exportsÂ
Alongside Digital Certificate of Pharmaceutical Product, DRAP Clearance Gateway now offers Free Sale Certificate, Good Manufacturing Practice Certificate, and No Objection Certificate for exports; initiative to enhance regulatory efficiency
Citi Pharma submits offers for acquisition of leading pharma companyÂ
Non-binding offer is part of Citi’s strategic expansion plans to become largest pharma firmÂ
DRAP orders immediate recall of substandard veterinary injection
Zaktyl-20 batch found substandard; authorities warn of therapy failure and drug resistance risks
Searle is lagging the pharmaceutical sector. Its recovery might be just around the corner
The pharmaceutical company has had lackluster numbers in recent times. All that might be about to change
Pharma sector earnings rise 3.1x to Rs24.8bn in 2024, driven by 15% rise in net sales
Net sales reach Rs318bn, gross margins improve to 36%, while finance costs rise to Rs8bn in 2024; deregulation of drug prices boosts profitability.
NAB probes Rs1.25bn embezzlement in KP medicine procurement
Inquiry revealed corruption in medicine procurement, with over Rs4 billion paid to 50 companies, 15 of which received more than Rs3 billion
Haleon Pakistan ships first consignment of Centrum multivitamin to Kenya
Shipment marks Pakistan's growing pharmaceutical exports and opens new international trade avenues.